Skip to content

Prime Medicine PRME Accounts Receivable

Accounts Receivable at other companies

Eli Lilly logo
Eli LillyLLY
$18.43B+53.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2B+10.6%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$9.13M-13.1%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$0
Regenxbio logo
RegenxbioRGNX
$10.04M-44.8%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$394.82M-40.1%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's accounts receivable?
Prime Medicine (PRME) reported accounts receivable of $0 in Q1 2026.
How has Prime Medicine's accounts receivable changed year-over-year?
Prime Medicine's accounts receivable decreased by 100.0% year-over-year, from $17K to $0.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.